Journal of the American Society of Hypertension
Volume 2, Issue 6 , Pages 418-424, November 2008

Ablation of angiotensin (1-7) receptor Mas in C57Bl/6 mice causes endothelial dysfunction

  • Luiza A. Rabelo, PhD

      Affiliations

    • Department of Physiology and Biophysics, Federal University of Minas Gerais, Belo Horizonte, Minas Gerais, Brazil
    • Laboratório de Reatividade Cardiovascular, Setor de Fisiologia, Instituto de Ciências Biológicas e da Saúde (ICBS), Universidade Federal de Alagoas, Maceió, Alagoas, Brazil
  • ,
  • Ping Xu

      Affiliations

    • Max-Delbrück-Center for Molecular Medicine, Berlin, Germany
  • ,
  • Mihail Todiras, MD

      Affiliations

    • Max-Delbrück-Center for Molecular Medicine, Berlin, Germany
  • ,
  • Walkyria O. Sampaio

      Affiliations

    • Department of Physiology and Biophysics, Federal University of Minas Gerais, Belo Horizonte, Minas Gerais, Brazil
  • ,
  • Jens Buttgereit, PhD

      Affiliations

    • Max-Delbrück-Center for Molecular Medicine, Berlin, Germany
  • ,
  • Michael Bader, PhD

      Affiliations

    • Max-Delbrück-Center for Molecular Medicine, Berlin, Germany
  • ,
  • Robson A.S. Santos, PhD

      Affiliations

    • Department of Physiology and Biophysics, Federal University of Minas Gerais, Belo Horizonte, Minas Gerais, Brazil
  • ,
  • Natalia Alenina, PhD

      Affiliations

    • Max-Delbrück-Center for Molecular Medicine, Berlin, Germany
    • Corresponding Author InformationCorresponding author: Natalia Alenina, PhD, Max-Delbrück-Center for Molecular Medicine (MDC), Robert-Rössle-Str. 10, D-13125 Berlin-Buch, Germany. Tel: +49 30 9406 3576; fax: +49 30 9406 2110

Received 2 March 2008; accepted 7 May 2008. published online 21 July 2008.

Abstract 

The Mas gene codes for an angiotensin (1-7) receptor. There is accumulating evidence that Mas is involved in vascular homeostasis. We have recently backcrossed Mas-knockout mice to two different genetic backgrounds, C57Bl/6 and FVB/N. FVB/NMas-deficient mice exhibited elevation in blood pressure (BP) and impaired endothelial function. In the present study, we aimed to address the question whether this phenotype is strain-specific. Therefore, we evaluated endothelial function in C57Bl/6Mas-deficient mice. Similar to FVB/NMas-knockout animals, Mas-deficiency in C57Bl/6 mice leads to endothelial dysfunction evaluated by the acute BP effect of acetylcholine administration. Measurements of nitric oxide (NO) and reactive oxygen species (ROS) and the systems involved in their metabolism revealed an imbalance between these vasoactive factors in C57Bl/6Mas-knockout mice, which may explain the impairment of endothelial function in these animals. However, endothelial dysfunction was less prominent in Mas-deficient mice on a C57Bl/6 background compared to FVB/N. Moreover, C57Bl/6Mas-deficient mice remained normotensive while FVB/N-based animals exhibited elevated BP. The impairment of endothelium-dependent vasodilatory response to acetylcholine in two different mouse strains with Mas deficiency indicates a key role of Mas in endothelial function by its effects on the generation and metabolism of NO and ROS.

Keywords: Mas-deficient mice, endothelial function, reactive oxygen species, nitric oxide

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 This study was supported by Fapemig/CNPq-Pronex (RASS) and DAAD/CAPES (PROBRAL). Part of the Proceedings of the Vasoactive Peptide Symposium, VII International Vasoactive Peptide Symposium in Ouro Preto, February 14–16, 2008.

 Conflict of interest: none.

PII: S1933-1711(08)00092-2

doi:10.1016/j.jash.2008.05.003

Journal of the American Society of Hypertension
Volume 2, Issue 6 , Pages 418-424, November 2008